Abraxas Petroleum Corporation (“Abraxas” or the “Company”) (NASDAQ:AXAS)
today announced its upcoming participation at the Stephens Fall
Investment Conference on Wednesday, November 12, 2014 at 9:00 AM EST.
By Marta Falconi
ZURICH--Swiss biotech company AC Immune said on Monday it had struck a deal potentially worth $509 million with a unit of Johnson & Johnson (JNJ) to develop vaccines against Alzheimer's disease, the most common form of dementia.
By Alex MacDonald
LONDON--Acacia Mining PLC (ACA.LN) is setting its sights on acquiring gold-producing assets as it starts to reap the rewards from its turnaround strategy, said the company's chief executive Friday.
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Innovative
Display Technologies LLC and Delaware Display Group LLC subsidiaries
have entered into a settlement and patent license agreement with HTC
Corporation and HTC America, Inc. The agreement resolves litigation that
was pending in the United States District Court for the District
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Brandywine
Communications Technologies LLC subsidiary entered into a
royalty-bearing patent license agreement with Gutierrez-Palmenberg, Inc.
dba Phoenix Internet.
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Super
Resolution Technologies LLC subsidiary and Carl Zeiss Microscopy,
LLC and Carl Zeiss Microscopy, GmbH have reached a resolution of their
dispute over the Fluorescent Nanoscopy patents.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.